Theriva Biologics Inc. (TOVX) shares have plummeted 15% after the company announced a 1-for-25 reverse stock split, effective August 26. The move aims to ensure the company meets NYSE American listing requirements. This article explores the implications of the reverse split and provides insights into potential investment strategies.